SCHWARTZ; Betty

Patent Applications and Registrations

Patent applications and USPTO patent grants for SCHWARTZ; Betty.The latest application filed is for "edible plant parts enriched with probiotic bacteria".

Company Profile

9.9.13

SCHWARTZ; Betty - Kibbutz Afek IL
SCHWARTZ; Betty - Rehovot IL
SCHWARTZ; Betty - Rechovot IL
- Rechovot IL
Schwartz; Betty - LeHavim IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Edible Plant Parts Enriched With Probiotic Bacteria App 20210030819 - SHOSEYOV; Oded ; et al.	2021-02-04
Method Of Treating A Liver Disease Comprising Administering Ostreolysin Orfunctionally Related Variant Thereof App 20200397848 - SCHWARTZ; Betty ; et al.	2020-12-24
Method of treating a liver disease comprising administering ostreolysin orfunctionally related variant thereof Grant 10,716,825 - Schwartz , et al.	2020-07-21
Method Of Treating Overweight Or Obesity Comprising Administering A Pleurotus Ostreatus Mushroom Extract Or A Composition Compri App 20200085905 - SCHWARTZ; Betty ; et al.	2020-03-19
Cryopreservation Method Of Biological Specimen App 20200077642 - BRASLAVSKY; Ido ; et al.	2020-03-12
Method Of Treating Overweight Or Obesity Comprising Administering A Pleurotus Ostreatus Mushroom Extract Or A Composition Compri App 20200061135 - SCHWARTZ; Betty ; et al.	2020-02-27
Method of treating overweight or obesity comprising administering a pleurotus ostreatus mushroom extract or a composition comprising a pleurotus ostretus mushroom extract Grant 10,493,123 - Schwartz , et al. De	2019-12-03
Ostreolysin, Functionally Related Variant Thereof, Extract Comprising Ostreolysin And Uses Thereof App 20170368133 - SCHWARTZ; Betty ; et al.	2017-12-28
Actin Binding Peptides And Compositions Comprising Same For Inhibiting Angiogenesis And Treating Medical Conditions Associated With Same App 20160340659 - SHOSEYOV; Oded ; et al.	2016-11-24
Methods of and compositions for inhibiting the proliferation of mammalian cells Grant 8,735,127 - Roiz , et al. May 27, 2	2014-05-27
Methods Of And Compositions For Inhibiting The Proliferation Of Mammalian Cells App 20140011729 - ROIZ; Levava ; et al.	2014-01-09
Methods of and compositions for inhibiting the proliferation of mammalian cells Grant 8,617,867 - Roiz , et al. December 31, 2	2013-12-31
Methods of and compositions for inhibiting the proliferation of mammalian cells Grant 08617867 -	2013-12-31
Methods of and compositions for inhibiting the proliferation of mammalian cells Grant 8,236,543 - Roiz , et al. August 7, 2	2012-08-07
Methods Of And Compositions For Inhibiting The Proliferation Of Mammalian Cells App 20120100128 - Roiz; Levava ; et al.	2012-04-26
Recombinant human T2 RNase and uses thereof Grant 8,039,240 - Roiz , et al. October 18, 2	2011-10-18
Efficient Expression Of Truncated Human Rnaset2 In E. Coli App 20110207667 - Shoseyou; Oded ; et al.	2011-08-25
Methods Of And Compositions For Inhibiting The Proliferation Of Mammalian Cells App 20110008314 - Roiz; Levava ; et al.	2011-01-13
Methods of and compositions for inhibiting the proliferation of mammalian cells Grant 7,811,981 - Roiz , et al. October 12, 2	2010-10-12
Recombinant Human T2 Rnase and Uses Thereof App 20080131419 - Roiz; Levava ; et al.	2008-06-05
Methods of and compositions for inhibiting the proliferation of mammalian cells Grant 7,101,839 - Roiz , et al. September 5, 2	2006-09-05
Methods of and compositions for inhibiting the proliferation of mammalian cells App 20050113327 - Roiz, Levava ; et al.	2005-05-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.